Rosa Coppolecchia

1.1k total citations · 1 hit paper
5 papers, 525 citations indexed

About

Rosa Coppolecchia is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Internal Medicine. According to data from OpenAlex, Rosa Coppolecchia has authored 5 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 2 papers in Pharmacology and 2 papers in Internal Medicine. Recurrent topics in Rosa Coppolecchia's work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Inflammatory mediators and NSAID effects (2 papers). Rosa Coppolecchia is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Inflammatory mediators and NSAID effects (2 papers). Rosa Coppolecchia collaborates with scholars based in United States, Germany and Italy. Rosa Coppolecchia's co-authors include Michał Tendera, Peter M. Rothwell, George Howard, Philip B. Gorelick, J. Michael Gaziano, Luís M. Ruilope, Gianni Tognoni, Thomas A. Pearson, Carlos Brotons and Claudio Cricelli and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Rosa Coppolecchia

4 papers receiving 509 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

2018 515 citations J. Michael Gaziano, Carlos Brotons et al. The Lancet profile →

Peers

Countries citing papers authored by Rosa Coppolecchia

Since Specialization

Citations

This map shows the geographic impact of Rosa Coppolecchia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Coppolecchia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Coppolecchia more than expected).

Fields of papers citing papers by Rosa Coppolecchia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Coppolecchia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Coppolecchia. The network helps show where Rosa Coppolecchia may publish in the future.

Co-authorship network of co-authors of Rosa Coppolecchia

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Coppolecchia. A scholar is included among the top collaborators of Rosa Coppolecchia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Coppolecchia. Rosa Coppolecchia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials 2024 ·Journal of the American College of Cardiology ·John W. Eikelboom, Hardi Mundl, John H. Alexander, Valeria Caso, Stuart J. Connolly, Rosa Coppolecchia, Martin Gebel, Robert G. Hart, Gerlind Holberg, (unknown), Manesh R. Patel, Jonathan P. Piccini, Sunil V. Rao, Ashkan Shoamanesh, Miriam Tamm, Thomas Viethen, Ashraf Yassen, Marc P. Bonaca	4
2	Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation 2024 ·SHILAP Revista de lepidopterología ·Vinai Bhagirath, (unknown), Jia Wang, Lizhen Xu, Shrikant I. Bangdiwala, Martin O’Donnell, Ashkan Shoamanesh, Jackie Bosch, Rosa Coppolecchia, (unknown), (unknown), Hardi Mundl, John W. Eikelboom	0
3	Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial breakdown → 2018 ·The Lancet ·J. Michael Gaziano, Carlos Brotons, Rosa Coppolecchia, Claudio Cricelli, Harald Darius, Philip B. Gorelick, George Howard, Thomas A. Pearson, Peter M. Rothwell, Luís M. Ruilope, Michał Tendera, Gianni Tognoni	515
4	Budget Impact of Appropriate Low-Dose Aspirin Use for Primary and Secondary Cardiovascular Event Prevention in the Managed Care Setting 2018 ·Journal of Managed Care & Specialty Pharmacy ·(unknown), Rosa Coppolecchia, (unknown), (unknown), (unknown), Todd Williamson, Jennifer Cameron	2
5	Antiplatelet effects of aspirin with phytosterols: Comparison with non-enteric coated aspirin alone 2009 ·Thrombosis Research ·Mark J. Antonino, Rosa Coppolecchia, Elisabeth Mahla, Kevin P. Bliden, Udaya S. Tantry, Paul A. Gurbel	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact